|
by Bill Roberts - This oral anabolic-androgenic
steroid was synthesized and approved under the brand
name Nilevar as the first orally-active AAS in 1956.
Norethandrolone has moderate progestagenic activity.
I don't have information on whether
Winstrol counteracts
this, as appears to be the case with
Anadrol®, but in any case
it is not considered a particularly useful drug
for male bodybuilders. For female bodybuilders,
it is probably an average synthetic, comparable
to Dianabol. It shares
the liver toxicity issues common to 17-alkylated
steroids.
It probably has low conversion to
estrogen (contrary to claims made elsewhere).
Norethandrolone is the
chemical name of active ingredient in Nilevar.
Nilevar was originally a registered trademark
of Searle Laboratories in the United States and/or
other countries prior to cancellation.
|
|
| Substance name |
Norethandrolone [INN] |
| Chemical name |
17-Hydroxy-19-nor-17a-pregn-4-en-3-one
|
| Systematic name |
(8R,9S,10R,13S,14S,17S)-17-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one |
| Index name |
19-Norpregn-4-en-3-one, 17-hydroxy-,
(17alpha)- |
| CAS number |
52-78-8 |
| Merck Index Number |
Merck 11, 6613 |
| Molecular formula |
C20-H30-O2 |
| Molecular weight |
302.455 g/mol |
| Legal status |
Prescription
only (US); DEA Schedule III (US) |
| Routes of administration |
Oral |
Visit Our Forums to Learn More About Anabolic Steroids
Publication Date:
March 22, 2001
|
